Summary
Biogen Idec Inc. (BIIB) filed an 8-K report on October 25, 2012, to announce its financial results for the third quarter ended September 30, 2012. This filing primarily serves to furnish a press release detailing the company's operational performance and financial condition during the period. Investors should note that the press release, incorporated by reference in this 8-K, contains the substantive information regarding the company's performance. While the 8-K itself is a procedural filing, the accompanying press release is the key document for understanding Biogen Idec's financial health and operational achievements in Q3 2012.
Key Highlights
- 1Biogen Idec announced its Q3 2012 financial results via a press release furnished with this 8-K.
- 2The filing date is October 25, 2012, reporting on the three months ended September 30, 2012.
- 3The press release (Exhibit 99) is the primary source of detailed financial and operational information.
- 4This 8-K filing is procedural, primarily to incorporate the press release by reference.
- 5Information regarding revenue, profitability, and other key performance indicators would be found within the furnished press release.
- 6The filing does not contain new material events beyond the release of quarterly financial results.
Frequently Asked Questions
The main purpose of this 8-K filing is to formally announce and provide access to Biogen Idec's financial results for the third quarter of 2012, through the incorporation of a press release.
The detailed financial information and operational results for Q3 2012 are contained within the press release issued by Biogen Idec on October 25, 2012, which is furnished as Exhibit 99 to this 8-K filing.
No, the press release furnished as part of this 8-K is not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. It is furnished rather than filed.
This specific 8-K filing is primarily focused on reporting quarterly financial results. Any material business developments or updated risk factors would be detailed within the accompanying press release; however, the 8-K itself does not introduce new information beyond the financial results announcement.